Cargando…

Recent advances in nanotherapeutics for the treatment and prevention of acute kidney injury

Acute kidney injury (AKI) is a serious kidney disease without specific medications currently except for expensive dialysis treatment. Some potential drugs are limited due to their high hydrophobicity, poor in vivo stability, low bioavailability and possible adverse effects. Besides, kidney-targeted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Hui, Liu, Di, Shu, Gaofeng, Jin, Feiyang, Du, Yongzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shenyang Pharmaceutical University 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520043/ https://www.ncbi.nlm.nih.gov/pubmed/34703493 http://dx.doi.org/10.1016/j.ajps.2020.11.001

Ejemplares similares

Recent advances in nanotherapeutics for the treatment of burn wounds
por: Huang, Rong, et al.
Publicado: (2021)

ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury
por: Yu, Hui, et al.
Publicado: (2020)

Recent Advances in Nanotherapeutics for Multiple Myeloma
por: Iannazzo, Daniela, et al.
Publicado: (2020)

Recent Advances in Nanotherapeutics for Neurological Disorders
por: Vashist, Arti, et al.
Publicado: (2023)

ZnO nanotherapeutics for the treatment of burn wounds: recent advances: Correspondence
por: Hemmami, Hadia, et al.
Publicado: (2023)

Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017)

Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease
por: Si, Xiao-Ying, et al.
Publicado: (2016)

Nanotherapeutics in the treatment of acute respiratory distress syndrome
por: Prasanna, Pragya, et al.
Publicado: (2021)

Nanotherapeutic modulation of excitotoxicity and oxidative stress in acute brain injury
por: Liao, Rick, et al.
Publicado: (2020)

Recent Strategies to Address Hypoxic Tumor Environments in Photodynamic Therapy
por: Du, Yuyin, et al.
Publicado: (2022)

Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems
por: Patel, Vimal, et al.
Publicado: (2021)

Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
por: Hattab, Dima, et al.
Publicado: (2021)

Recent advances in the understanding of acute kidney injury
por: Tögel, Florian, et al.
Publicado: (2014)

Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
por: Segura-Ibarra, Victor, et al.
Publicado: (2018)

Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor
por: Wei, Xiao, et al.
Publicado: (2022)

Recent Advances of Proteomics in Management of Acute Kidney Injury
por: Pejchinovski, Ilinka, et al.
Publicado: (2023)

Polymeric nanomaterials for nanotherapeutics
por: Vasile, Cornelia
Publicado: (2018)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

How Advanced are Cancer Immuno-Nanotherapeutics? A Comprehensive Review of the Literature
por: Yadav, Dhananjay, et al.
Publicado: (2023)

Chemoreactive Nanotherapeutics by Metal Peroxide Based Nanomedicine
por: Hu, Hui, et al.
Publicado: (2020)

Vascular targeted nanotherapeutic approach for obesity treatment
por: Sibuyi, Nicole Remaliah Samantha, et al.
Publicado: (2018)

Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke
por: Choudhary, Manisha, et al.
Publicado: (2023)

Nanotherapeutics with immunoregulatory functions for the treatment of bacterial infection
por: Yang, Dongliang, et al.
Publicado: (2023)

RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity
por: Smith, Jayden A., et al.
Publicado: (2017)

Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation
por: Miyata, Masahiro, et al.
Publicado: (2022)

Recent Progresses in Cancer Nanotherapeutics Design Using Artemisinins as Free Radical Precursors
por: Wu, Yalan, et al.
Publicado: (2020)

ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule
por: Liu, Di, et al.
Publicado: (2020)

Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model
por: Huang, Liandi, et al.
Publicado: (2021)

Nanotherapeutics for treating coronavirus diseases
por: Gunathilake, Thennakoon M. Sampath U., et al.
Publicado: (2021)

Smart Nanotherapeutics and Lung Cancer
por: Doroudian, Mohammad, et al.
Publicado: (2021)

Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
por: Yan, Huize, et al.
Publicado: (2019)

Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death
por: Jin, Feiyang, et al.
Publicado: (2021)

Intelligent nanotherapeutic strategies for the delivery of CRISPR system
por: Chen, Chao, et al.
Publicado: (2023)

Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers
por: Jayant, Rahul Dev, et al.
Publicado: (2018)

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021)

The emerging potential of siRNA nanotherapeutics in treatment of arthritis
por: Kumari, Anjali, et al.
Publicado: (2023)

Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury
por: Cantoni, Claudia, et al.
Publicado: (2020)

Peptide-siRNA nanotherapeutics in arthritis
por: Pham, Christine T.N., et al.
Publicado: (2015)

Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
por: Leggio, Loredana, et al.
Publicado: (2020)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tvfkoa9a488iqv0mu21sfu68dg